Diseases, Conditions, Syndromes

FDA approves first RSV vaccine

The first vaccine for respiratory syncytial virus (RSV) has been approved by the U.S. Food and Drug Administration for use in seniors aged 60 and older.

Vaccination

EU watchdog backs GSK's RSV vaccine for over 60s

The European Union's drug watchdog has recommended approval of pharmaceutical giant GSK's vaccine against the RSV respiratory virus for over-60s, the British firm said on Thursday.

Diseases, Conditions, Syndromes

Exposure to air pollution during pregnancy increases risk for flu

During pregnancy, women are more susceptible to severe respiratory infections from multiple viruses, including influenza A virus (IAV), respiratory syncytial virus (RSV) and severe acute respiratory syndrome coronavirus (SARS-CoV-2). ...

Diseases, Conditions, Syndromes

RSV hospitalizations spiked unusually high in late 2021, study finds

The COVID-19 pandemic posed an immense challenge for the health care industry in 2020 and 2021. While hospitals were inundated with COVID-19 cases, other illnesses such as respiratory syncytial virus (RSV) saw a decrease ...

page 13 from 40